Corbus Pharmaceuticals Holdings, Inc. Derivative Liability, Current
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Derivative Liability, Current of $0 as of 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2025-03-11
- 2024-12-31: Derivative Liability, Current $0.00.
- 2024-09-30: Derivative Liability, Current $0.00.
- 2024-06-30: Derivative Liability, Current $0.00.
- 2024-03-31: Derivative Liability, Current $10.88K.
| Period end | Derivative Liability, Current | Derivative Liability, Current as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-11 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $10.88K 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $39.00K 10-K · filed 2025-03-11 | $39.45K 10-K · filed 2024-03-12 |
| 2023-09-30 | $36.87K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $36.87K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $36.87K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $36.87K 10-K · filed 2024-03-12 | |
| 2022-09-30 | $133.71K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $133.71K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $133.71K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $133.71K 10-K · filed 2023-03-07 | |
| 2021-09-30 | $126.86K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $599.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $803.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $797.00K 10-K · filed 2022-03-08 | |
| 2020-09-30 | $757.00K 10-Q · filed 2020-11-09 | |
| 2014-06-30 | $18.41K 10-Q · filed 2015-08-13 | |
| 2013-12-31 | $19.93K 10-K · filed 2015-02-10 | |
| 2013-03-31 | $18.41K 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |